Table 1:
Characteristics of participants and HIV transmission risk behaviors, stratified by willingness to use LAI-PrEP (Bivariate associations; N=234).
| Variables | Entire Sample (N = 234) | Willingness to use LAI-PrEPe | OR f (95% CI g) | p | |||
|---|---|---|---|---|---|---|---|
| Frequency | % | No (n = 62) | Yes (n = 172) | ||||
| Characteristics of participants | |||||||
| Age: Mean (±SD), years a | 42.7 (±10.2) | 41.5 (±10.6) | 43.1 (±10.0) | 1.016 (0.987, 1.046) | 0.283 | ||
| Sex | |||||||
| Male | 119 | 50.9 | 40 (17.1) | 79 (33.8) | - | - | |
| Female | 115 | 49.1 | 22 (9.4) | 93 (39.7) | 2.140 (1.174, 3.902) | 0.013 | |
| Heterosexual sexual orientation | |||||||
| No | 49 | 20.9 | 12 (5.1) | 37 (15.8) | - | - | |
| Yes | 185 | 79.1 | 50 (21.4) | 135 (57.7) | 0.876 (0.423, 1.803) | 0.721 | |
| Ethnicity | |||||||
| Non-White | 86 | 36.8 | 22 (9.4) | 64 (27.4) | - | - | |
| White | 148 | 63.2 | 40 (17.1) | 108 (46.2) | 0.928 (0.507, 1.700) | 0.809 | |
| Currently married/living with partner | |||||||
| No | 183 | 78.2 | 46 (19.7) | 137 (58.5) | - | - | |
| Yes | 51 | 21.8 | 16 (6.8) | 35 (15.0) | 0.734 (0.372, 1.449) | 0.373 | |
| High school graduate | |||||||
| No | 65 | 27.8 | 16 (6.8) | 49 (20.9) | - | - | |
| Yes | 169 | 72.2 | 46 (19.7) | 123 (52.6) | 0.873 (0.452, 1.686) | 0.686 | |
| Employed | |||||||
| No | 205 | 87.6 | 52 (22.2) | 153 (65.4) | - | - | |
| Yes | 29 | 12.4 | 10 (4.3) | 19 (8.1) | 0.646 (0.282, 1.478) | 0.300 | |
| Income level | |||||||
| < $10,000 | 68 | 29.1 | 18 (7.7) | 50 (21.4) | - | - | |
| ≥ $10,000 | 166 | 70.9 | 44 (18.8) | 1 22 (54.1) | 0.998 (0.527, 1.892) | 0.996 | |
| Homelessb | |||||||
| No | 103 | 44.0 | 26 (11.1) | 77 (32.9) | - | - | |
| Yes | 131 | 56.0 | 36 (15.4) | 95 (40.6) | 0.891 (0.495, 1.603) | 0.700 | |
| Visited healthcare providerb | |||||||
| No | 27 | 11.5 | 12 (5.1) | 15 (6.4) | - | - | |
| Yes | 207 | 88.5 | 50 (21.4) | 157 (67.1) | 2.512 (1.103, 5.721) | 0.028 | |
| Methadone Dose (mg): Mean (±SD) a | 81.9 (±30.5) | 86.9 (±31.2) | 80.0 (±30.2) | 0.992 (0.983, 1.002) | 0.129 | ||
| Moderate to severe depression | |||||||
| No | 60 | 25.6 | 16 (6.8) | 44 (18.8) | - | - | |
| Yes | 174 | 74.4 | 46 (19.7) | 128 (54.7) | 1.012 (0.521, 1.966) | 0.972 | |
| Alcohol use disorder | |||||||
| No | 161 | 68.8 | 45 (19.2) | 116 (49.6) | - | - | |
| Yes | 73 | 31.2 | 17 (7.3) | 56 (23.9) | 1.278 (0.672, 2.430) | 0.455 | |
| HIV transmission risk behaviors | |||||||
| Duration of drug use: Mean (±SD a) years | 18.4 (±10.1) | 18.3 (±10.3) | 18.4 (±10.1) | 1.001 (0.973, 1.031) | 0.926 | ||
| Used illicit drug c | |||||||
| No | 74 | 31.6 | 22 (9.4) | 52 (22.2) | - | - | |
| Yes | 160 | 68.4 | 40 (17.1) | 120 (51.3) | 1.269 (0.687, 2.344) | 0.446 | |
| Injected any illicit drug c | n = 160 | ||||||
| No | 55 | 23.5 | 15 (9.4) | 40 (25.0) | - | - | |
| Yes | 105 | 44.9 | 25 (15.6) | 80 (80 (50.0) | 1.200 (0.570, 2.526) | 0.631 | |
| Shared injection equipment c | n = 105 | ||||||
| No | 62 | 26.5 | 15 (14.3) | 47 (44.8) | - | - | |
| Yes | 43 | 18.4 | 10 (9.5) | 33 (31.4) | 1.053 (0.422, 2.631) | 0.912 | |
| Engaged in sexual intercourse c | |||||||
| No | 67 | 28.6 | 18 (7.7) | 49 (20.9) | - | - | |
| Yes | 167 | 71.4 | 44 (18.8) | 123 (52.6) | 1.027 (0.541, 1.949) | 0.935 | |
| Multiple sex partner c | n = 167 | ||||||
| No | 75 | 32.1 | 23 (13.8) | 52 (31.1) | - | - | |
| Yes | 92 | 39.3 | 21 (12.6) | 71 (42.5) | 1.495 (0.749, 2.985) | 0.254 | |
| Consistent condom use c | n = 167 | ||||||
| No | 153 | 65.4 | 41 (24.6) | 112 (67.1) | - | - | |
| Yes | 14 | 6.0 | 3 (1.8) | 11 (6.6) | 1.342 (0.356, 5.054) | 0.663 | |
| Engaged in transactional sex c | n = 167 | ||||||
| No | 121 | 51.7 | 36 (21.6) | 85 (50.9) | - | - | |
| Yes | 46 | 19.7 | 8 (4.8) | 38 (22.8) | 2.012 (0.854, 4.736) | 0.110 | |
| Sex under the influence of alcohol c | n = 167 | ||||||
| No | 94 | 40.2 | 29 (17.4) | 65 (38.9) | - | - | |
| Yes | 73 | 31.2 | 15 (9.0) | 58 (34.7) | 1.725 (0.842, 3.533) | 0.136 | |
| Perceived risk of HIV transmission | |||||||
| Low | 175 | 74.8 | 54 (23.1) | 121 (51.7) | - | - | |
| High | 59 | 25.2 | 8 (3.4) | 51 (21.8) | 2.845 (1.264, 6.404) | 0.012 | |
| Satisfied with current method of HIV prevention | |||||||
| No | 89 | 38.0 | 22 (9.4) | 67 (28.6) | - | - | |
| Yes | 145 | 62.0 | 40 (17.1) | 105 (44.9) | 0.862 (0.471, 1.577) | 0.630 | |
| PrEP-specific variablesd | |||||||
| Heard of oral PrEP | |||||||
| No | 77 | 32.9 | 28 (12.0) | 49 (20.9) | - | - | |
| Yes | 157 | 67.1 | 34 (14.5) | 123 (52.6) | 2.067 (1.135, 3.766) | 0.018 | |
| Ever used oral PrEP | |||||||
| No | 174 | 32.9 | 56 (23.9) | 118 (50.4) | - | - | |
| Yes | 60 | 25.6 | 6 (2.6) | 54 (23.1) | 4.271 (1.734, 10.520) | 0.002 | |
| Heard of LAI-PrEP e | |||||||
| No | 174 | 74.4 | 50 (21.4) | 124 (53.0) | - | - | |
| Yes | 60 | 25.6 | 12 (5.1) | 48 (20.5) | 1.613 (0.791, 3.290) | 0.189 | |
Note:
SD: standard deviation;
in the past 12 months;
in the past 30 days;
PrEP: pre-exposure prophylaxis;
LAI-PrEP: long-acting injectable PrEP;
odds ratio;
confidence interval